Internal Medicine, Endocrinology, Diabetes, & Metabolism · Pompton Plains, NJ
NPI
1386855849
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
242 W Parkway
Pompton Plains, NJ, 07444
Phone (862) 248-8165
Groups this clinician bills Medicare through
Medicare paid, 2024
$82K
2,514 services
Medicare patients, 2024
352
Average age 71
Drug cost, 2024
$2.1M
4,057 prescriptions
Company payments, 2025
$1,947
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Uzma Z Shafqat was code J0897 (injection, denosumab, 1 mg), 1,140 times for 13 patients. In total Uzma Z Shafqat billed 2,514 services in 24 codes, and Medicare paid $82K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,140 | 13 | $20.63 | $24K |
| 99214 Office E&M - Established | Office | 266 | 210 | $96.91 | $26K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 200 | 172 | $13.63 | $2,726 |
| 99204 Office E&M - New | Office | 73 | 73 | $117.54 | $8,581 |
| 95251 Test - Miscellaneous | Office | 37 | 32 | $28.26 | $1,046 |
| 99205 Office E&M - New | Office | 33 | 33 | $168.41 | $5,557 |
| 96372 Injection Administration | Office | 25 | 15 | $11.59 | $290 |
| 99215 Office E&M - Established | Office | 20 | 18 | $156.82 | $3,136 |
| 99223 Hospital E&M - Initial | Facility | 19 | 19 | $146.39 | $2,781 |
| 99222 Hospital E&M - Initial | Facility | 15 | 14 | $98.45 | $1,477 |
By year: 2022 $66K for 1,765 services; 2023 $81K for 3,756 services; 2024 $82K for 2,514 services.
Medicare prescription drug claims, 2024
In 2024, the drug Uzma Z Shafqat prescribed most often to Medicare patients was Levothyroxine Sodium, with 425 prescriptions and refills. In total Uzma Z Shafqat wrote 4,057 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 425 | 1,071 | 132 | $4,347 |
| Jardiance Empagliflozin | 360 | 625 | 77 | $358K |
| Trulicity Dulaglutide | 305 | 389 | 55 | $369K |
| Metformin Hcl Generic | 267 | 695 | 94 | $2,707 |
| Ozempic Semaglutide | 221 | 336 | 55 | $303K |
| Farxiga Dapagliflozin Propanediol | 202 | 318 | 44 | $175K |
| Metformin Hcl Er Metformin Hcl | 198 | 470 | 67 | $2,016 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 193 | 507 | 75 | $21K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 155 | 372 | 61 | $14K |
| Mounjaro Tirzepatide | 133 | 143 | 26 | $143K |
| Alendronate Sodium Generic | 125 | 311 | 42 | $746 |
| Methimazole Generic | 118 | 284 | 34 | $1,669 |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 104 | 238 | 38 | $38K |
| Atorvastatin Calcium Generic | 86 | 208 | 30 | $600 |
| Tradjenta Linagliptin | 65 | 98 | 12 | $47K |
Brand drugs: 2,316 claims; generic drugs: 1,427 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Uzma Z Shafqat $1,947 ($1,947 in general payments such as food, travel and fees) from 30 companies. The largest payer was Corcept Therapeutics with $179.
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics CORT | 9 | $179 |
| Novo Nordisk Inc NVO | 9 | $159 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 12 | $152 |
| Lilly USA, LLC LLY | 8 | $144 |
| Mannkind Corporation MNKD | 9 | $143 |
| Insulet Corporation PODD | 4 | $100 |
| Amgen Inc. AMGN | 6 | $98.49 |
| Xeris Pharmaceuticals, Inc. | 5 | $91.39 |
| Abbott Laboratories ABT | 4 | $89.04 |
| Tandem Diabetes Care, Inc. TNDM | 3 | $85.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.